Enhancing the QUAlity and Transparency Of health Research

Website translation help
Navigate this website
Home > Library > Reporting guideline > Proposed best practice for statisticians in the reporting and publication of pharmaceutical industry-sponsored clinical trials

Search for reporting guidelines

Use your browser's Back button to return to your search results

Proposed best practice for statisticians in the reporting and publication of pharmaceutical industry-sponsored clinical trials

Reporting guideline provided for?
(i.e. exactly what the authors state in the paper)		 Pharmaceutical industry-sponsored clinical trials
Full bibliographic reference Matcham J, Julious S, Pyke S, O'Kelly M, Todd S, Seldrup J, Day S. Proposed best practice for statisticians in the reporting and publication of pharmaceutical industry-sponsored clinical trials. Pharm Stat. 2011;10(1):70-73.
Language English
PubMed ID 20187020
Study design Clinical trials, Experimental studies
Clinical area Pharmaceutical medicine
Applies to the whole report or to individual sections of the report? Conflict of interest, Ethical issues (consent etc.), Statistical methods and analyses
Record last updated on August 20, 2013

Reporting guidelines for main study types

Translations

Some reporting guidelines are also available in languages other than English. Find out more in our Translations section.

About the Library

For information about Library scope and content, identification of reporting guidelines and inclusion/exclusion criteria please visit About the Library.

Visit our Help page for information about searching for reporting guidelines and for general information about using our website.

Library index